Annie Olivier

599 total citations
12 papers, 492 citations indexed

About

Annie Olivier is a scholar working on Organic Chemistry, Oncology and Cell Biology. According to data from OpenAlex, Annie Olivier has authored 12 papers receiving a total of 492 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Organic Chemistry, 5 papers in Oncology and 4 papers in Cell Biology. Recurrent topics in Annie Olivier's work include Quinazolinone synthesis and applications (6 papers), HER2/EGFR in Cancer Research (4 papers) and Proteoglycans and glycosaminoglycans research (4 papers). Annie Olivier is often cited by papers focused on Quinazolinone synthesis and applications (6 papers), HER2/EGFR in Cancer Research (4 papers) and Proteoglycans and glycosaminoglycans research (4 papers). Annie Olivier collaborates with scholars based in France and United Kingdom. Annie Olivier's co-authors include Rémy Morgentin, Laurent Hennequin, Christine Lambert‐van der Brempt, Patrick A. Plé, Gerard Costello, Nicolas Warin, Jon Curwen, J. Breed, Michael Fennell and Tim P. Green and has published in prestigious journals such as Journal of Medicinal Chemistry, International Journal of Cancer and European Journal of Cancer.

In The Last Decade

Annie Olivier

12 papers receiving 479 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Annie Olivier France 10 262 160 153 68 46 12 492
Venkat R. Pallela United States 17 246 0.9× 278 1.7× 208 1.4× 49 0.7× 73 1.6× 25 738
Marcel Koenig United States 11 281 1.1× 121 0.8× 150 1.0× 66 1.0× 26 0.6× 17 500
Christina Esdar Germany 15 460 1.8× 86 0.5× 182 1.2× 63 0.9× 82 1.8× 38 698
Rémy Morgentin France 13 292 1.1× 301 1.9× 173 1.1× 21 0.3× 58 1.3× 23 624
Thomas E. Rawson United States 8 601 2.3× 168 1.1× 262 1.7× 73 1.1× 20 0.4× 17 857
D. Mark Hickinson United Kingdom 11 234 0.9× 80 0.5× 250 1.6× 37 0.5× 125 2.7× 14 501
Stephen M. Courtney United Kingdom 12 346 1.3× 215 1.3× 95 0.6× 124 1.8× 109 2.4× 15 572
Babette Aicher Germany 11 423 1.6× 140 0.9× 105 0.7× 48 0.7× 22 0.5× 28 607
Nicolas Warin United Kingdom 4 222 0.8× 111 0.7× 115 0.8× 18 0.3× 50 1.1× 7 394
Vincent Bordas United Kingdom 8 511 2.0× 280 1.8× 125 0.8× 55 0.8× 47 1.0× 14 836

Countries citing papers authored by Annie Olivier

Since Specialization
Citations

This map shows the geographic impact of Annie Olivier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annie Olivier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annie Olivier more than expected).

Fields of papers citing papers by Annie Olivier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annie Olivier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annie Olivier. The network helps show where Annie Olivier may publish in the future.

Co-authorship network of co-authors of Annie Olivier

This figure shows the co-authorship network connecting the top 25 collaborators of Annie Olivier. A scholar is included among the top collaborators of Annie Olivier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annie Olivier. Annie Olivier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Bardelle, Catherine, Bernard Barlaam, Nigel Brooks, et al.. (2010). Inhibitors of the tyrosine kinase EphB4. Part 3: Identification of non-benzodioxole-based kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(21). 6242–6245. 30 indexed citations
2.
Barlaam, Bernard, David Acton, Peter Ballard, et al.. (2008). Neutral 5-substituted 4-indazolylaminoquinazolines as potent, orally active inhibitors of erbB2 receptor tyrosine kinase. Bioorganic & Medicinal Chemistry Letters. 18(6). 1799–1803. 10 indexed citations
3.
Barlaam, Bernard, Peter Ballard, Robert H. Bradbury, et al.. (2007). A new series of neutral 5-substituted 4-anilinoquinazolines as potent, orally active inhibitors of erbB2 receptor tyrosine kinase. Bioorganic & Medicinal Chemistry Letters. 18(2). 674–678. 18 indexed citations
4.
5.
Ballard, Peter, Robert H. Bradbury, Craig S. Harris, et al.. (2005). Inhibitors of epidermal growth factor receptor tyrosine kinase: Novel C-5 substituted anilinoquinazolines designed to target the ribose pocket. Bioorganic & Medicinal Chemistry Letters. 16(6). 1633–1637. 31 indexed citations
6.
Ballard, Peter, Robert H. Bradbury, Laurent Hennequin, et al.. (2005). 5-Substituted 4-anilinoquinazolines as potent, selective and orally active inhibitors of erbB2 receptor tyrosine kinase. Bioorganic & Medicinal Chemistry Letters. 15(19). 4226–4229. 31 indexed citations
7.
Barlaam, Bernard, Tim Green, Laurent Hennequin, et al.. (2005). New heterocyclic analogues of 4-(2-chloro-5-methoxyanilino)quinazolines as potent and selective c-Src kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 15(24). 5446–5449. 23 indexed citations
8.
Maingonnat, Catherine, et al.. (1997). Production d'hyaluronidase par les cellules cancéreuses humaines en culture. Comptes Rendus de l Académie des Sciences - Series III - Sciences de la Vie. 320(10). 805–810. 12 indexed citations
9.
Delpech, Bertrand, Nicole Girard, Annie Olivier, et al.. (1997). The origin of hyaluronectin in human tumors. International Journal of Cancer. 72(6). 942–948. 23 indexed citations
10.
Delpech, Bertrand, Nicole Girard, Annie Olivier, et al.. (1997). The origin of hyaluronectin in human tumors. International Journal of Cancer. 72(6). 942–948. 2 indexed citations
11.
Bird, Chris, et al.. (1996). Inhibitors of leukotriene B4. Synthesis and sar of new ß-enaminoester open-chain analogues of zeneca ZD2138. Bioorganic & Medicinal Chemistry Letters. 6(5). 515–520. 8 indexed citations
12.
Chauzy, Claude, Bertrand Delpech, Annie Olivier, et al.. (1992). Establishment and characterisation of a human glioma cell line. European Journal of Cancer. 28(6-7). 1129–1134. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Venkat R. Pallela Breakdown of academic impact, for papers by Marcel Koenig Breakdown of academic impact, for papers by Christina Esdar Breakdown of academic impact, for papers by Rémy Morgentin Breakdown of academic impact, for papers by Thomas E. Rawson Breakdown of academic impact, for papers by D. Mark Hickinson Breakdown of academic impact, for papers by Stephen M. Courtney Breakdown of academic impact, for papers by Babette Aicher Breakdown of academic impact, for papers by Nicolas Warin Breakdown of academic impact, for papers by Vincent Bordas
Rankless by CCL
2026